"532-03-6"@en . . "Humans and other mammals"@en . "Symptoms of overdose include blurred vision, coma, drowsiness, low blood pressure, nausea, and seizures."@en . . . . . . . . . . . . . . . . . "1.14-1.24 hours"@en . . "Avoid alcohol."@en . . "Methocarbamolum"@en . . . . . . . . . . . . . . . . . . . . . . . . . . "Metocarbamol"@en . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "M\u00E9thocarbamol"@en . . . . . . " "@en . . . . "Rapid. Onset of action is about 30 minutes after oral administration."@en . . . . . . . . . . . "Delaxin"@en . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "* 0.2 \u2013 0.8 L/h/kg [healthy]"@en . . . "Small amounts of unchanged methocarbamol also are excreted in the urine."@en . . "Methocarbamol"@en . . . . . . . . "Take without regard to meals."@en . . . "Metocarbamolo"@en . "Methocarbamol"@en . "(RS)-2-hydroxy-3-(2-methoxyphenoxy)propyl carbamate"@en . "The mechanism of action of methocarbamol in humans has not been established, but may be due to central nervous system depression. It has no direct action on the contractile mechanism of striated muscle, the motor end plate or the nerve fiber."@en . . "Robaxin"@en . . . . "# Sica DA, Comstock TJ, Davis J, Manning L, Powell R, Melikian A, Wright G: Pharmacokinetics and protein binding of methocarbamol in renal insufficiency and normals. Eur J Clin Pharmacol. 1990;39(2):193-4. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/2253675"@en . "For use as an adjunct to rest, physical therapy, and other measures for the relief of discomforts associated with acute, painful musculoskeletal conditions."@en . "approved"@en . . . . "A centrally acting muscle relaxant whose mode of action has not been established. It is used as an adjunct in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1206)"@en . . . . . . . . . .